Angiotensin receptor blockers

Angiotensin Receptor Blockers (ARBs), also known as angiotensin II receptor antagonists, are a group of pharmaceuticals used primarily to manage hypertension (high blood pressure) and heart failure. They function by blocking the effects of angiotensin II, a potent chemical that causes muscles surrounding blood vessels to contract, thereby narrowing the vessels. This narrowing increases the pressure within the vessels and can lead to high blood pressure. By inhibiting the action of angiotensin II, ARBs cause the blood vessels to relax and widen, which lowers blood pressure and improves blood flow.

Mechanism of Action

ARBs work by selectively blocking the binding of angiotensin II to the AT1 receptor in various tissues throughout the body, such as the heart, blood vessels, kidney, and adrenal gland. Unlike ACE inhibitors, which prevent the formation of angiotensin II, ARBs do not affect the breakdown of bradykinin, potentially reducing the risk of certain side effects.

Indications

The primary indications for ARBs include:

• Hypertension: ARBs are often used as a first-line treatment or in combination with other antihypertensive agents.
• Heart failure: They are beneficial in patients who are intolerant to ACE inhibitors.
• Chronic kidney disease: ARBs can slow the progression of kidney damage, particularly in patients with diabetes.
• Diabetic nephropathy: They are effective in reducing proteinuria and slowing the progression of kidney disease in patients with diabetes.

Common ARBs

Some of the commonly prescribed ARBs include:

• Losartan
• Valsartan
• Irbesartan
• Candesartan
• Telmisartan
• Olmesartan

Side Effects

While generally well-tolerated, ARBs can cause some side effects, including:

• Dizziness
• Hyperkalemia (high potassium levels)
• Renal impairment
• Fatigue
• Rarely, angioedema (swelling similar to hives but under the skin)

Comparison with ACE Inhibitors

ARBs and ACE inhibitors are both used to treat similar conditions, but ARBs are often preferred for patients who experience a persistent cough as a side effect of ACE inhibitors. Additionally, the risk of angioedema is lower with ARBs compared to ACE inhibitors.

Conclusion

Angiotensin Receptor Blockers are a vital part of the therapeutic arsenal against hypertension, heart failure, and chronic kidney disease. Their ability to block the action of angiotensin II offers a significant benefit in managing these conditions, with a side effect profile that is generally considered favorable.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian